Publications

March 2021 (Revised January 2023)
Case

The Trouble with TCE

By: Vincent Pons, Rafael Di Tella and Galit Goldstein

Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details

Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States

02 May 2017
First Look

First Look at New Research: May 2, 2017

April 14, 2017 Harvard Business Review Companies Like United Need to Cultivate Good Judgment, and Free Their Employees to Use It By: Deighton, John A. Abstract—United Airlines has pledged to improve its training programs and empower its... View Details

Keywords: Carmen Nobel

2024
Working Paper

The Effects of Medical Debt Relief: Evidence from Two Randomized Experiments

By: Raymond Kluender, Neale Mahoney, Francis Wong and Wesley Yin

Two in five Americans have medical debt, nearly half of whom owe at least $2,500. Concerned by this burden, governments and private donors have undertaken large, high-profile efforts to relieve medical debt. We partnered with RIP Medical Debt to conduct two randomized... View Details

Keywords: Borrowing and Debt; Credit; Outcome or Result; Well-being; Personal Finance

Read Now

2000
Chapter

Anticipating Greener Supply Chain Demands: One Singapore Company's Journey to ISO 14001

By: Michael W. Toffel

One major benefit of Jebsen & Jessen Packaging Pte Ltd (JJPS’s) implementation of ISO 14001 is that it acquired a third-party 'seal of approval' that will be used in its marketing efforts to meet the growing environmental concern of its customers within the electronics... View Details

Keywords: Supply Chain Management; Corporate Social Responsibility and Impact; Standards; Environmental Sustainability; Singapore

Read Now

February 2024
Article

Representation and Extrapolation: Evidence from Clinical Trials

By: Marcella Alsan, Maya Durvasula, Harsh Gupta, Joshua Schwartzstein and Heidi L. Williams

This article examines the consequences and causes of low enrollment of Black patients in clinical trials. We develop a simple model of similarity-based extrapolation that predicts that evidence is more relevant for decision-making by physicians and patients when it... View Details

Keywords: Representation; Racial Disparity; Health Testing and Trials; Race; Equality and Inequality; Innovation and Invention; Pharmaceutical Industry

July–September 2018
Article

Memory Bias in Observer-Performance Literature

By: Tamara M. Haygood, Samantha N. Smith and Jia Sun

The objective of our study was to determine how authors of published observer–performance experiments dealt with memory bias in study design. We searched American Journal of Roentgenology online and Radiology using “observer study” and “observer performance.” We... View Details

Keywords: Health Care and Treatment; Research

Read Now

Program

Creating Brand Value

facilitate your growth. Your learning will take place on your own, in your living group, and in the larger classroom, driven by the renowned HBS case method. Review Our Campus Health & Safety Protocols Admissions Criteria and Process We... View Details

03 Sep 2013
News

With Change Coming, Aetna Targets Employers

July 2011 (Revised September 2012)
Case

Intraoperative Radiotherapy for Breast Cancer (A)

By: Willy Shih

"This trial is going to take longer." Those were words that Michael Kaschke, CEO of Carl Zeiss AG, was not surprised to hear as he nurtured the intraoperative radiotherapy business inside his company's microsurgery unit. But he also didn't expect it to take 13 years to... View Details

Keywords: Finance; Business History; Disruptive Innovation; Emerging Markets; Organizational Change and Adaptation; Research and Development; Safety

31 Jan 2017
News

All The Single Ladies - Women Who Downplay Their Successes And Why It’s a Huge Mistake

04 May 2017
News

The Error at the Heart of Corporate Leadership

24 Mar 2011
Working Paper Summaries

Individual Rationality and Participation in Large Scale, Multi-Hospital Kidney Exchanges

Keywords: by Itai Ashlagi & Alvin E. Roth; Health

02 Jan 2024
Research & Ideas

10 Trends to Watch in 2024

The lightning-fast ascent of generative AI isn’t the only sea change on the horizon for businesses in the new year. The global economy is in flux as war, climate change, trade issues, and infrastructure problems demand attention. Many companies continue to struggle to... View Details

Keywords: by Rachel Layne

September 2017 (Revised July 2023)
Case

Adaptive Platform Trials: The Clinical Trial of the Future?

By: Ariel D. Stern and Sarah Mehta

In July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial—an adaptive platform trial—to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer.... View Details

Keywords: Clinical Trials; Cancer; Adaptive Platform Trials; Platform Trials; Adaptive Trials; Glioblastoma; Health; Health Care and Treatment; Health Testing and Trials; Business Strategy; Innovation Strategy; Health Industry; United States